;PMID: 1606041
;source_file_846.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..52] = [t:0..52]
;1)sentence:[e:58..190] = [t:58..190]
;2)section:[e:194..231] = [t:194..231]
;3)section:[e:235..292] = [t:235..292]
;4)sentence:[e:296..497] = [t:296..497]
;5)sentence:[e:498..772] = [t:498..772]
;6)sentence:[e:773..838] = [t:773..838]
;7)sentence:[e:839..918] = [t:839..918]
;8)sentence:[e:919..1167] = [t:919..1167]
;9)sentence:[e:1168..1367] = [t:1168..1367]
;10)sentence:[e:1368..1482] = [t:1368..1482]
;11)sentence:[e:1483..1629] = [t:1483..1629]
;12)section:[e:1633..1677] = [t:1633..1677]

;section 0 Span:0..52
;J Steroid Biochem Mol Biol. 1992 May;42(3-4):287-92.
(SEC
  (FRAG (NNP:[0..1] J) (NNP:[2..9] Steroid) (NNP:[10..17] Biochem)
        (NNP:[18..21] Mol) (NNP:[22..26] Biol) (IN:[26..27] .)
        (CD:[28..32] 1992) (NNP:[33..36] May) (CD:[36..41] ;42-LRB-3)
        (::[41..42] -) (CD:[42..44] 4-RRB-) (CD:[44..48] :287) (::[48..49] -)
        (CD:[49..51] 92) (.:[51..52] .)))

;sentence 1 Span:58..190
;Inhibition mechanism of reconstituted cytochrome P-450scc-linked
;monooxygenase  system by antimycotic reagents and other inhibitors.
;[96..115]:cyp450:"cytochrome P-450scc"
;[123..136]:substance:"monooxygenase"
;[148..168]:substance:"antimycotic reagents"
;[179..189]:substance:"inhibitors"
(SENT
  (NP-HLN
    (NP (NN:[58..68] Inhibition) (NN:[69..78] mechanism))
    (PP (IN:[79..81] of)
      (NP
        (NML (VBD:[82..95] reconstituted)
          (ADJP
            (NML (NN:[96..106] cytochrome) (NN:[107..115] P-450scc))
            (HYPH:[115..116] -) (JJ:[116..122] linked))
          (NN:[123..136] monooxygenase))
        (NN:[138..144] system)))
    (PP (IN:[145..147] by)
      (NP
        (NP (JJ:[148..159] antimycotic) (NNS:[160..168] reagents))
        (CC:[169..172] and)
        (NP (JJ:[173..178] other) (NNS:[179..189] inhibitors))))
    (.:[189..190] .)))

;section 2 Span:194..231
;Kurokohchi K, Nishioka M, Ichikawa Y.
(SEC
  (FRAG (NNP:[194..204] Kurokohchi) (NNP:[205..206] K) (,:[206..207] ,)
        (NNP:[208..216] Nishioka) (NNP:[217..219] M,) (NNP:[220..228] Ichikawa)
        (NNP:[229..231] Y.)))

;section 3 Span:235..292
;Department of Biochemistry, Kagawa Medical School, Japan.
(SEC
  (FRAG (NNP:[235..245] Department) (IN:[246..248] of)
        (NNP:[249..261] Biochemistry) (,:[261..262] ,) (NNP:[263..269] Kagawa)
        (NNP:[270..277] Medical) (NNP:[278..284] School) (,:[284..285] ,)
        (NNP:[286..291] Japan) (.:[291..292] .)))

;sentence 4 Span:296..497
;The effects of various antimycotic reagents and some other reagents on a 
;cytochrome P-450-linked monooxygenase system were investigated with respect
;to  the activities of NADPH-ferricyanide reductase.
;[319..339]:substance:"antimycotic reagents"
;[355..363]:substance:"reagents"
;[370..386]:cyp450:"cytochrome P-450"
;[394..407]:substance:"monooxygenase"
;[468..496]:substance:"NADPH-ferricyanide reductase"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[296..299] The) (NNS:[300..307] effects))
      (PP (IN:[308..310] of)
        (NP
          (NP (JJ:[311..318] various)
             (JJ:[319..330] antimycotic) (NNS:[331..339] reagents))
          (CC:[340..343] and)
          (NP (DT:[344..348] some) (JJ:[349..354] other)
              (NNS:[355..363] reagents))))
      (PP (IN:[364..366] on)
        (NP (DT:[367..368] a)
          (NML
            (ADJP
              (NP (NN:[370..380] cytochrome) (NN:[381..386] P-450))
              (HYPH:[386..387] -) (VBN:[387..393] linked))
            (NN:[394..407] monooxygenase))
          (NN:[408..414] system))))
    (VP (VBD:[415..419] were)
      (VP (VBN:[420..432] investigated)
        (NP-1 (-NONE-:[432..432] *))
        (PP (IN:[433..437] with)
          (NP
            (NP (NN:[438..445] respect))
            (PP (TO:[446..448] to)
              (NP
                (NP (DT:[450..453] the) (NNS:[454..464] activities))
                (PP (IN:[465..467] of)
                  (NP (NN:[468..486] NADPH-ferricyanide)
                      (NN:[487..496] reductase)))))))))
    (.:[496..497] .)))

;sentence 5 Span:498..772
;NADPH-cytochrome c reductase of  NADPH-adreno-ferredoxin reductase from NADPH
;to cytochrome c via  adreno-ferredoxin, NADPH-cytochrome
;P-450-phenylisocyanide complex reductase,  and the cholesterol side chain
;cleavage of the cytochrome P-450scc-linked  monooxygenase system.
;[498..526]:substance:"NADPH-cytochrome c reductase"
;[531..564]:substance:"NADPH-adreno-ferredoxin reductase"
;[570..575]:substance:"NADPH"
;[579..591]:cyp450:"cytochrome c"
;[597..614]:substance:"adreno-ferredoxin"
;[616..673]:substance:"NADPH-cytochrome P-450-phenylisocyanide complex
;reductase"
;[684..715]:substance:"cholesterol side chain cleavage"
;[723..742]:cyp450:"cytochrome P-450scc"
;[751..764]:substance:"monooxygenase"
(SENT
  (FRAG
    (NP
      (NP
        (NP
          (NML (NN:[498..514] NADPH-cytochrome) (NN:[515..516] c))
          (NN:[517..526] reductase))
        (PP (IN:[527..529] of)
          (NP (NN:[531..554] NADPH-adreno-ferredoxin) (NN:[555..564] reductase))))
      (PP (IN:[565..569] from)
        (NP (NN:[570..575] NADPH)))
      (PP (TO:[576..578] to)
        (NP (NN:[579..589] cytochrome) (NN:[590..591] c))))
    (PP (IN:[592..595] via)
      (NP
        (NP (NN:[597..614] adreno-ferredoxin))
        (,:[614..615] ,)
        (NP
          (NML (NN:[616..632] NADPH-cytochrome)
               (NN:[633..655] P-450-phenylisocyanide) (NN:[656..663] complex))
          (NN:[664..673] reductase))
        (,:[673..674] ,) (CC:[676..679] and)
        (NP
          (NP (DT:[680..683] the)
             (NN:[684..695] cholesterol)
            (NML (NN:[696..700] side) (NN:[701..706] chain))
            (NN:[707..715] cleavage))
          (PP (IN:[716..718] of)
            (NP (DT:[719..722] the)
              (NML
                (ADJP
                  (NML (NN:[723..733] cytochrome) (NN:[734..742] P-450scc))
                  (HYPH:[742..743] -) (JJ:[743..749] linked))
                (NN:[751..764] monooxygenase))
              (NN:[765..771] system))))))
    (.:[771..772] .)))

;sentence 6 Span:773..838
;No reagents inhibited the NADPH-ferricyanide reductase  activity.
;[776..784]:substance:"reagents"
;[799..827]:substance:"NADPH-ferricyanide reductase"
(SENT
  (S
    (NP-SBJ (DT:[773..775] No) (NNS:[776..784] reagents))
    (VP (VBD:[785..794] inhibited)
      (NP (DT:[795..798] the)
        (NML (NN:[799..817] NADPH-ferricyanide) (NN:[818..827] reductase))
        (NN:[829..837] activity)))
    (.:[837..838] .)))

;sentence 7 Span:839..918
;Only cloconazole inhibited about 50% of NADPH-cytochrome c reductase 
;activity.
;[844..855]:substance:"cloconazole"
;[872..875]:quantitative-value:"50%"
;[879..907]:substance:"NADPH-cytochrome c reductase"
(SENT
  (S
    (NP-SBJ (RB:[839..843] Only) (NN:[844..855] cloconazole))
    (VP (VBD:[856..865] inhibited)
      (NP
        (NP
          (QP (IN:[866..871] about) (CD:[872..874] 50))
          (NN:[874..875] %))
        (PP (IN:[876..878] of)
          (NP
            (NML
              (NML (NN:[879..895] NADPH-cytochrome) (NN:[896..897] c))
              (NN:[898..907] reductase))
            (NN:[909..917] activity)))))
    (.:[917..918] .)))

;sentence 8 Span:919..1167
;Cloconazole, econazole, clotrimazole, etomidate and ketoconazole  inhibited
;both NADPH-cytochrome P-450-phenylisocyanide complex reductase and the  side
;chain cleavage activity of cholesterol of the cytochrome P-450scc-linked 
;monooxygenase system.
;[919..930]:substance:"Cloconazole"
;[932..941]:substance:"econazole"
;[943..955]:substance:"clotrimazole"
;[957..966]:substance:"etomidate"
;[971..983]:substance:"ketoconazole"
;[1000..1057]:substance:"NADPH-cytochrome P-450-phenylisocyanide complex
;reductase"
;[1099..1110]:substance:"cholesterol"
;[1118..1137]:cyp450:"cytochrome P-450scc"
;[1146..1159]:substance:"monooxygenase"
(SENT
  (S
    (NP-SBJ (NN:[919..930] Cloconazole) (,:[930..931] ,)
            (NN:[932..941] econazole) (,:[941..942] ,)
            (NN:[943..955] clotrimazole) (,:[955..956] ,)
            (NN:[957..966] etomidate) (CC:[967..970] and)
            (NN:[971..983] ketoconazole))
    (VP (VBD:[985..994] inhibited)
      (NP (CC:[995..999] both)
        (NP
          (NML (NN:[1000..1016] NADPH-cytochrome)
               (NN:[1017..1039] P-450-phenylisocyanide)
               (NN:[1040..1047] complex))
          (NN:[1048..1057] reductase))
        (CC:[1058..1061] and)
        (NP
          (NP (DT:[1062..1065] the)
            (NML
              (NML (NN:[1067..1071] side) (NN:[1072..1077] chain))
              (NN:[1078..1086] cleavage))
            (NN:[1087..1095] activity))
          (PP (IN:[1096..1098] of)
            (NP
              (NP (NN:[1099..1110] cholesterol))
              (PP (IN:[1111..1113] of)
                (NP (DT:[1114..1117] the)
                  (NML
                    (ADJP
                      (NML (NN:[1118..1128] cytochrome)
                           (NN:[1129..1137] P-450scc))
                      (HYPH:[1137..1138] -) (VBN:[1138..1144] linked))
                    (NN:[1146..1159] monooxygenase))
                  (NN:[1160..1166] system))))))))
    (.:[1166..1167] .)))

;sentence 9 Span:1168..1367
;Cloconazole, econazole, etomidate and ketoconazole behaved  like
;non-competitive inhibitors for NADPH-cytochrome P-450-phenylisocyanide 
;reductase activities and their Ki values were 10(-4)-10(-6) M.
;[1168..1179]:substance:"Cloconazole"
;[1181..1190]:substance:"econazole"
;[1192..1201]:substance:"etomidate"
;[1206..1218]:substance:"ketoconazole"
;[1249..1259]:substance:"inhibitors"
;[1264..1314]:substance:"NADPH-cytochrome P-450-phenylisocyanide  reductase"
;[1336..1338]:quantitative-name:"Ki"
;[1351..1364]:quantitative-value:"10(-4)-10(-6)"
;[1365..1366]:quantitative-units:"M"
(SENT
  (S
    (S
      (NP-SBJ (NN:[1168..1179] Cloconazole) (,:[1179..1180] ,)
              (NN:[1181..1190] econazole) (,:[1190..1191] ,)
              (NN:[1192..1201] etomidate) (CC:[1202..1205] and)
              (NN:[1206..1218] ketoconazole))
      (VP (VBD:[1219..1226] behaved)
        (PP-CLR (IN:[1228..1232] like)
          (NP
            (NP
              (ADJP (AFX:[1233..1236] non) (HYPH:[1236..1237] -)
                    (JJ:[1237..1248] competitive))
              (NNS:[1249..1259] inhibitors))
            (PP (IN:[1260..1263] for)
              (NP
                (NML
                  (NML (NN:[1264..1280] NADPH-cytochrome)
                       (NN:[1281..1303] P-450-phenylisocyanide))
                  (NN:[1305..1314] reductase))
                (NNS:[1315..1325] activities)))))))
    (CC:[1326..1329] and)
    (S
      (NP-SBJ (PRP$:[1330..1335] their) (NN:[1336..1338] Ki)
              (NNS:[1339..1345] values))
      (VP (VBD:[1346..1350] were)
        (NP-PRD
          (NP (CD:[1351..1357] 10-LRB--4-RRB-))
          (PP (HYPH:[1357..1358] -)
            (NP (CD:[1358..1364] 10-LRB--6-RRB-) (NN:[1365..1366] M))))))
    (.:[1366..1367] .)))

;sentence 10 Span:1368..1482
;Cloconazole was a  non-competitive inhibitor of NADPH-cytochrome c reductase
;and its Ki value was  8.3 x 10(-4) M.
;[1368..1379]:substance:"Cloconazole"
;[1403..1412]:substance:"inhibitor"
;[1416..1444]:substance:"NADPH-cytochrome c reductase"
;[1453..1455]:quantitative-name:"Ki"
;[1467..1479]:quantitative-value:"8.3 x 10(-4)"
;[1480..1481]:quantitative-units:"M"
(SENT
  (S
    (S
      (NP-SBJ (NN:[1368..1379] Cloconazole))
      (VP (VBD:[1380..1383] was)
        (NP-PRD
          (NP (DT:[1384..1385] a)
            (ADJP (AFX:[1387..1390] non) (HYPH:[1390..1391] -)
                  (JJ:[1391..1402] competitive))
            (NN:[1403..1412] inhibitor))
          (PP (IN:[1413..1415] of)
            (NP
              (NML (NN:[1416..1432] NADPH-cytochrome) (NN:[1433..1434] c))
              (NN:[1435..1444] reductase))))))
    (CC:[1445..1448] and)
    (S
      (NP-SBJ (PRP$:[1449..1452] its) (NN:[1453..1455] Ki)
              (NN:[1456..1461] value))
      (VP (VBD:[1462..1465] was)
        (NP-PRD
          (QP (CD:[1467..1470] 8.3) (SYM:[1471..1472] x)
              (CD:[1473..1479] 10-LRB--4-RRB-))
          (NN:[1480..1481] M))))
    (.:[1481..1482] .)))

;sentence 11 Span:1483..1629
;Cloconazole, clotrimazole, econazole, etomidate, ketoconazole  and mitotane
;completely inhibited the side chain cleavage activity of  cholesterol.
;[1483..1494]:substance:"Cloconazole"
;[1496..1508]:substance:"clotrimazole"
;[1510..1519]:substance:"econazole"
;[1521..1530]:substance:"etomidate"
;[1532..1544]:substance:"ketoconazole"
;[1550..1558]:substance:"mitotane"
;[1617..1628]:substance:"cholesterol"
(SENT
  (S
    (NP-SBJ (NN:[1483..1494] Cloconazole) (,:[1494..1495] ,)
            (NN:[1496..1508] clotrimazole) (,:[1508..1509] ,)
            (NN:[1510..1519] econazole) (,:[1519..1520] ,)
            (NN:[1521..1530] etomidate) (,:[1530..1531] ,)
            (NN:[1532..1544] ketoconazole) (CC:[1546..1549] and)
            (NN:[1550..1558] mitotane))
    (VP
      (ADVP (RB:[1559..1569] completely))
      (VBD:[1570..1579] inhibited)
      (NP
        (NP (DT:[1580..1583] the)
          (NML
            (NML (NN:[1584..1588] side) (NN:[1589..1594] chain))
            (NN:[1595..1603] cleavage))
          (NN:[1604..1612] activity))
        (PP (IN:[1613..1615] of)
          (NP (NN:[1617..1628] cholesterol)))))
    (.:[1628..1629] .)))

;section 12 Span:1633..1677
;PMID: 1606041 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1633..1637] PMID) (::[1637..1638] :) (CD:[1639..1646] 1606041)
        (NN:[1647..1648] -LSB-) (NNP:[1648..1654] PubMed) (::[1655..1656] -)
        (NN:[1657..1664] indexed) (IN:[1665..1668] for)
        (NNP:[1669..1677] MEDLINE-RSB-)))
